admin – Page 64 – Get News Story

Alport Syndrome Market Trends, Innovation, and Future Growth Outlook to 2036 – DelveInsight | Eloxx Pharmac, Biogen, River 3 Renal Corp, Travere Therapeutics, Chinook Therapeutics

The Key Alport Syndrome Companies in the market include – Eloxx Pharmaceuticals, Inc., Biogen, River 3 Renal Corp., Travere Therapeutics, Inc. , Chinook Therapeutics U.S., Inc., Bayer, and others.

DelveInsight’s “Alport Syndrome Market Insights, Epidemiology, and Market Forecast-2036″ report offers an in-depth understanding of the Alport Syndrome, historical and forecasted epidemiology as well as the Alport Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

Get a Free sample for the Alport Syndrome Market Forecast, Size & Share Analysis Report:

https://www.delveinsight.com/report-store/alport-syndrome-market

Some of the key facts of the Alport Syndrome Market Report:

The Alport Syndrome market size was valued at nearly USD 20 million in 2025 and is expected to expand at a notable CAGR of 39% during the forecast period from 2026 to 2036.
Alport syndrome is a rare genetic kidney disorder caused by mutations in the type IV collagen genes (COL4A3, COL4A4, and COL4A5), resulting in abnormalities in the glomerular basement membrane and characterized by progressive kidney dysfunction, hearing loss, and ocular complications.
In December 2025, Bayer announced the launch of a Phase IIa clinical trial evaluating BAY 3401016, an investigational monoclonal antibody designed to inhibit Semaphorin 3A (Sema3A), a protein implicated in kidney damage progression in Alport Syndrome (AS), a rare genetic disorder. The first-in-patient ASSESS study (NCT07211685) is a randomized, double-blind, placebo-controlled trial with a group-comparison and extension phase, aiming to assess the safety and efficacy of BAY 3401016 in adults with Alport Syndrome.
In June 2025, ENYO Pharma, a clinical-stage biotech company specializing in FXR agonists for treating serious kidney disorders, has announced the successful progression of its Phase 2 ALPESTRIA-1 trial involving 26 patients with Alport syndrome. Topline results are expected in the fourth quarter of 2025. Simultaneously, ENYO has completed its Series C funding round with an additional €6 million investment from Vesalius Biocapital IV, raising the total to €32 million.
In 2025, the the US accounted for the maximum share of the total market in the 7MM, i.e.,59%, followed by Germany capturing nearly 9% share. The total market size in the 7MM for Alport Syndrome was estimated to be USD 20 million in 2025, which is expected to show positive growth by 2036.
Among the 7MM countries, the United States accounted for the largest market size for Alport syndrome. The market size for Alport Syndrome was USD 12 million in the United States in 2025. Due to the emergence of novel therapies, the overall market size of Alport Syndrome would experience an increase in the United States during the forecast period.
Alport syndrome is caused by mutations in the genes responsible for alpha-3, alpha-4, and alpha-5 chains of type IV collagen. The prevalence of Alport syndrome is not well-documented but is believed to be found in about 1 in every 50,000 live births worldwide.
The total diagnosed prevalent cases of Alport syndrome in the 7MM were 29,500 cases in 2025 and are projected to rise by 2036.
In 2025, EU4 and the UK accounted for 7,000 cases in males and 6,400 cases in females. These cases are expected to increase to 9,441 cases and 8,715 cases in males and females, respectively by 2036.
In 2025, the 18 years and above age segment accounted for the highest number of cases in EU4 and the UK i.e, 11,400 cases whereas, the 12-17 years age segment had the least number of cases accounting for 870 cases. These cases are expected to increase by 2036.
Key Alport Syndrome Companies: Eloxx Pharmaceuticals, Inc., Biogen, River 3 Renal Corp., Travere Therapeutics, Inc. , Chinook Therapeutics U.S., Inc., Bayer, and others
Key Alport Syndrome Therapies: ELX-02, Bardoxolone Methyl, R3R01, Sparsentan, Atrasentan, Finerenone, and others
In 2022, there were around 2,200 cases of Alport syndrome in the age group 2-11, nearly 1,900 cases in the age group 12-17, and almost 25,000 cases in the age group 18 and above across the 7 Major Markets (7MM).
The Alport Syndrome market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Alport Syndrome pipeline products will significantly revolutionize the Alport Syndrome market dynamics.

Alport Syndrome Overview

Alport Syndrome is a genetic disorder characterized by kidney disease, hearing loss, and eye abnormalities. It primarily affects the glomeruli, the tiny blood vessels in the kidneys that filter wastes and excess fluids from the blood to form urine. This condition typically results from mutations in genes that encode proteins involved in the structure and function of the glomeruli and the inner ear.

To Know in detail about the Alport Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Alport Syndrome Market Forecast

Alport Syndrome Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2022 to 2036. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Alport Syndrome Epidemiology Segmentation:

The Alport Syndrome market report proffers epidemiological analysis for the study period 2022–2036 in the 7MM segmented into:

Total Prevalent Cases of Alport syndrome
Total Diagnosed Prevalent of Alport syndrome
Gender-specific Cases of Alport syndrome
Age-specific Cases of Alport syndrome
Type-specific Cases of Alport syndrome

Download the report to understand which factors are driving Alport Syndrome epidemiology trends @ Alport Syndrome Epidemiology Forecast

Alport Syndrome Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Alport Syndrome market or expected to get launched during the study period. The analysis covers Alport Syndrome market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Alport Syndrome Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Alport Syndrome Therapies and Key Companies

ELX-02: Eloxx Pharmaceuticals, Inc.
Bardoxolone Methyl: Biogen
R3R01: River 3 Renal Corp.
Sparsentan: Travere Therapeutics, Inc.
Atrasentan: Chinook Therapeutics U.S., Inc.
Finerenone: Bayer

Discover more about therapies set to grab major Alport Syndrome market share @ Alport Syndrome Treatment Landscape

Alport Syndrome Market Drivers

Increasing Awareness of Rare Genetic Disorders: Growing awareness among healthcare professionals and patients regarding inherited kidney diseases is supporting earlier diagnosis and treatment of Alport syndrome.
Advancements in Genetic Testing: Improvements in molecular diagnostics and genetic screening technologies are enhancing the identification of COL4A3, COL4A4, and COL4A5 gene mutations associated with Alport syndrome.
Strong Pipeline Development: Ongoing research activities and clinical trials focused on targeted therapies, gene therapies, and novel nephrology treatments are driving market growth.
Rising Investments in Rare Disease Research: Increased funding from pharmaceutical companies, research organizations, and government agencies for rare disease drug development is accelerating innovation.

Alport Syndrome Market Barriers

Rare Disease Population: The low prevalence of Alport syndrome limits the patient pool, creating challenges for large-scale clinical trials and commercial viability.
Limited Approved Therapies: Currently available treatment options mainly focus on symptom management rather than providing a definitive cure for the disease.
High Treatment Costs: Advanced therapies, genetic testing, and long-term renal care can be expensive, limiting accessibility in certain regions.
Challenges in Early Diagnosis: Due to overlapping symptoms with other kidney disorders, Alport syndrome is often underdiagnosed or misdiagnosed.
Complexity of Genetic Mutations: Variability in genetic mutations and disease progression complicates

Scope of the Alport Syndrome Market Report

Study Period: 2022–2036
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
Key Alport Syndrome Companies: Eloxx Pharmaceuticals, Inc., Biogen, River 3 Renal Corp., Travere Therapeutics, Inc. , Chinook Therapeutics U.S., Inc., Bayer, and others
Key Alport Syndrome Therapies: ELX-02, Bardoxolone Methyl, R3R01, Sparsentan, Atrasentan, Finerenone, and others
Alport Syndrome Therapeutic Assessment: Alport Syndrome current marketed and Alport Syndrome emerging therapies
Alport Syndrome Market Dynamics: Alport Syndrome market drivers and Alport Syndrome market barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Alport Syndrome Unmet Needs, KOL’s views, Analyst’s views, Alport Syndrome Market Access and Reimbursement

To know more about Alport Syndrome companies working in the treatment market, visit @ Alport Syndrome Clinical Trials and Therapeutic Assessment

Table of Contents

1. Alport Syndrome Market Report Introduction

2. Executive Summary for Alport Syndrome

3. SWOT analysis of Alport Syndrome

4. Alport Syndrome Patient Share (%) Overview at a Glance

5. Alport Syndrome Market Overview at a Glance

6. Alport Syndrome Disease Background and Overview

7. Alport Syndrome Epidemiology and Patient Population

8. Country-Specific Patient Population of Alport Syndrome

9. Alport Syndrome Current Treatment and Medical Practices

10. Alport Syndrome Unmet Needs

11. Alport Syndrome Emerging Therapies

12. Alport Syndrome Market Outlook

13. Country-Wise Alport Syndrome Market Analysis (2022–2036)

14. Alport Syndrome Market Access and Reimbursement of Therapies

15. Alport Syndrome Market Drivers

16. Alport Syndrome Market Barriers

17. Alport Syndrome Appendix

18. Alport Syndrome Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: https://www.delveinsight.com/
Country: United States
Website: https://www.delveinsight.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Alport Syndrome Market Trends, Innovation, and Future Growth Outlook to 2036 – DelveInsight | Eloxx Pharmac, Biogen, River 3 Renal Corp, Travere Therapeutics, Chinook Therapeutics

Excessive Daytime Sleepiness Market Emerging as a High-Growth Healthcare Investment Space Through 2036 – DelveInsight | Avadel Pharma, Axsome Therapeutics, Theranexus, Suven LifeSciences, NLS Pharma

The Key Excessive Daytime Sleepiness Companies in the market include – Avadel Pharmaceuticals, Axsome Therapeutics, Theranexus, Suven LifeSciences, NLS Pharma, XWPharma, Balance Therapeutics, Takeda Pharmaceuticals, Benevolent AI Bio, Avadel Pharmaceuticals, and others.

DelveInsight’s “Excessive Daytime Sleepiness Market Insights, Epidemiology, and Market Forecast-2036″ report offers an in-depth understanding of the Excessive Daytime Sleepiness, historical and forecasted epidemiology as well as the Excessive Daytime Sleepiness market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

Get a Free sample for the Excessive Daytime Sleepiness Market Report:

https://www.delveinsight.com/report-store/excessive-daytime-sleepiness-eds-market

Some of the key facts of the Excessive Daytime Sleepiness Market Report:

The Excessive Daytime Sleepiness market size was valued at approximately USD 7,500 million in 2025 and is anticipated to grow at a CAGR of 3% during the forecast period from 2026 to 2036.
XYWAV generated the highest revenue in the narcolepsy segment, reaching approximately USD 1,130 million in 2025.
Several therapies are approved across the 7MM for the treatment of Excessive Daytime Sleepiness, including PROVIGIL/MODIODAL (modafinil), NUVIGIL (armodafinil), SUNOSI (solriamfetol), WAKIX (pitolisant), XYWAV (calcium, magnesium, potassium, and sodium oxybates), and XYREM (sodium oxybate). Generic versions of PROVIGIL/MODIODAL, NUVIGIL, and XYREM are also available in the US market.
In February 2026, Wakix (pitolisant) is a prescription therapy indicated for narcolepsy, a chronic neurological sleep disorder characterized by excessive daytime sleepiness and, in many patients, cataplexy sudden episodes of muscle weakness often triggered by strong emotions. The U.S. Food and Drug Administration (FDA) has approved Wakix for the treatment of cataplexy in pediatric patients aged 6 years and older who have narcolepsy.
In January 2025, Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing treatments for hypertension, chronic kidney disease (CKD), and other conditions driven by dysregulated aldosterone, has announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) Application. This approval allows the company to conduct a Phase 2 clinical trial to assess the effects of lorundrostat in treating patients with moderate-to-severe obstructive sleep apnea (OSA) and hypertension.
The total number of diagnosed prevalent cases of Excessive Daytime Sleepiness in the 7MM was around 7,800,000 in 2025.
The United States encompasses the highest diagnosed prevalent population of Excessive Daytime Sleepiness, around 4,200,000 in 2025.
Among EU4 and the UK, the UK accounts for the highest number of diagnosed prevalent cases of Excessive Daytime Sleepiness, whereas Spain accounts for the least number of prevalent cases.
As per the DelveInsight analysis, it was observed that Japan accounted for approximately 16% of the diagnosed prevalent population of Excessive Daytime Sleepiness among 7MM, in the year 2025.
Key Excessive Daytime Sleepiness Companies: Avadel Pharmaceuticals, Axsome Therapeutics, Theranexus, Suven LifeSciences, NLS Pharma, XWPharma, Balance Therapeutics, Takeda Pharmaceuticals, Benevolent AI Bio, Avadel Pharmaceuticals, and others
Key Excessive Daytime Sleepiness Therapies: FT218, THN102, SUVN-G3031, Quilience, XW10172, TAK-994, BEN-2001, AXS-12 (Reboxetine), Xywav (JZP-258) for EDS in IH, Wakix (Pitolisant) for EDS in OSA, and others
The Excessive Daytime Sleepiness epidemiology based diagnosed prevalent cases analyzed that in the US, the majority of the cases of EDS are found in OSA and Bipolar disorder, followed by Parkinson’s Disease, Narcolepsy, and Idiopathic Hypersomnia
The Excessive Daytime Sleepiness market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Excessive Daytime Sleepiness pipeline products will significantly revolutionize the Excessive Daytime Sleepiness market dynamics.

Excessive Daytime Sleepiness Overview

The condition known as excessive daytime sleepiness (EDS) is characterised by difficulty remaining awake and alert during the day’s main waking periods, with sleep happening accidentally or at inopportune times.

To Know in detail about the Excessive Daytime Sleepiness market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Excessive Daytime Sleepiness Market Forecast

Excessive Daytime Sleepiness Epidemiology

Excessive Daytime Sleepiness Epidemiology Segmentation:

The Excessive Daytime Sleepiness market report proffers epidemiological analysis for the study period 2022–2036 in the 7MM segmented into:

Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness
Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Different Disorders
Total Treatable Cases of Excessive Daytime Sleepiness

Download the report to understand which factors are driving Excessive Daytime Sleepiness epidemiology trends @ Excessive Daytime Sleepiness Epidemiology Forecast

Excessive Daytime Sleepiness Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Excessive Daytime Sleepiness market or expected to get launched during the study period. The analysis covers Excessive Daytime Sleepiness market uptake by drugs, patient uptake by therapies, and sales of each drug.

The report also covers the Excessive Daytime Sleepiness Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Excessive Daytime Sleepiness Therapies and Key Companies

Pitolisant (WAKIX/OZAWADE): Bioprojet Pharma/Harmony Biosciences
Solriamfetol (SUNOSI): Jazz Pharmaceuticals
FT218: Avadel Pharmaceuticals
Xywav (calcium, magnesium, potassium, and sodium oxybates): Jazz Pharmaceuticals
Xyrem (sodium oxybate): Jazz Pharmaceuticals/UCB Pharma Ltd
Samelisant (SUVN-G3031): Suven Life Sciences
AXS-12: AxsomeTherapeutics
THN102: Theranexus
SUVN-G3031: Suven LifeSciences
Quilience: NLS Pharma
XW10172: XWPharma
TAK-994: Takeda

Discover more about therapies set to grab major Excessive Daytime Sleepiness market share @ Excessive Daytime Sleepiness Treatment Market

Excessive Daytime Sleepiness Market Drivers

Rising Prevalence of Sleep Disorders: Increasing cases of narcolepsy, obstructive sleep apnea, insomnia, and other neurological disorders are driving demand for Excessive Daytime Sleepiness (EDS) treatments.
Growing Awareness and Diagnosis Rates: Improved awareness regarding sleep health and advancements in diagnostic technologies are leading to earlier detection and treatment of EDS conditions.
Advancements in Therapeutics: The introduction of novel wake-promoting agents and innovative treatment approaches is expanding therapeutic options for EDS patients.
Increasing Healthcare Expenditure: Rising investments in sleep medicine, neurological care, and healthcare infrastructure are supporting market growth.

Excessive Daytime Sleepiness Market Barriers

High Treatment Costs: Premium pricing of branded therapies and long-term treatment expenses may limit patient accessibility in certain regions.
Availability of Generic Alternatives: The presence of generic versions of key EDS therapies creates pricing pressure for branded products.
Underdiagnosis of Sleep Disorders: Many EDS cases remain undiagnosed or misdiagnosed due to limited awareness and lack of specialized sleep centers.
Side Effects and Safety Concerns: Some wake-promoting drugs may be associated with cardiovascular, psychiatric, or dependency-related side effects, affecting patient adherence.
Stringent Regulatory Requirements: Complex clinical trial and approval processes for central nervous system (CNS) therapies can delay product launches.

Scope of the Excessive Daytime Sleepiness Market Report

Study Period: 2022–2036
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
Key Excessive Daytime Sleepiness Companies: Avadel Pharmaceuticals, Axsome Therapeutics, Theranexus, Suven LifeSciences, NLS Pharma, XWPharma, Balance Therapeutics, Takeda Pharmaceuticals, Benevolent AI Bio, Avadel Pharmaceuticals, and others
Key Excessive Daytime Sleepiness Therapies: FT218, THN102, SUVN-G3031, Quilience, XW10172, TAK-994, BEN-2001, AXS-12 (Reboxetine), Xywav (JZP-258) for EDS in IH, Wakix (Pitolisant) for EDS in OSA, and others
Excessive Daytime Sleepiness Therapeutic Assessment: Excessive Daytime Sleepiness current marketed and Excessive Daytime Sleepiness emerging therapies
Excessive Daytime Sleepiness Market Dynamics: Excessive Daytime Sleepiness market drivers and Excessive Daytime Sleepiness market barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Excessive Daytime Sleepiness Unmet Needs, KOL’s views, Analyst’s views, Excessive Daytime Sleepiness Market Access and Reimbursement

To know more about Excessive Daytime Sleepiness companies working in the treatment market, visit @ Excessive Daytime Sleepiness Clinical Trials and Therapeutic Assessment

Table of Contents

1. Excessive Daytime Sleepiness Market Report Introduction

2. Executive Summary for Excessive Daytime Sleepiness

3. SWOT analysis of Excessive Daytime Sleepiness

4. Excessive Daytime Sleepiness Patient Share (%) Overview at a Glance

5. Excessive Daytime Sleepiness Market Overview at a Glance

6. Excessive Daytime Sleepiness Disease Background and Overview

7. Excessive Daytime Sleepiness Epidemiology and Patient Population

8. Country-Specific Patient Population of Excessive Daytime Sleepiness

9. Excessive Daytime Sleepiness Current Treatment and Medical Practices

10. Excessive Daytime Sleepiness Unmet Needs

11. Excessive Daytime Sleepiness Emerging Therapies

12. Excessive Daytime Sleepiness Market Outlook

13. Country-Wise Excessive Daytime Sleepiness Market Analysis (2022–2036)

14. Excessive Daytime Sleepiness Market Access and Reimbursement of Therapies

15. Excessive Daytime Sleepiness Market Drivers

16. Excessive Daytime Sleepiness Market Barriers

17. Excessive Daytime Sleepiness Appendix

18. Excessive Daytime Sleepiness Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Excessive Daytime Sleepiness Market Emerging as a High-Growth Healthcare Investment Space Through 2036 – DelveInsight | Avadel Pharma, Axsome Therapeutics, Theranexus, Suven LifeSciences, NLS Pharma

Advance Surface Defect Detection Machine: Cost Reduction and Efficiency Enhancement Solution

Advance Surface Defect Detection Machine.png

Ⅱ、Core Advantages of Surface Defect Detection Machines for Cost Reduction and Efficiency Enhancement

(一) Cost Reduction

1.Substantial Reduction in Labor Costs

Traditional manual inspection requires a large workforce, and hiring skilled workers becomes increasingly difficult as labor costs rise. In contrast, surface defect detection machines enable 24/7/365 unattended inspection, eliminating concerns about worker fatigue and rest. One device can replace multiple inspectors, significantly reducing labor costs. In terms of efficiency comparison, image recognition inspection is several times faster than manual inspection, reducing investments in recruitment, training, and management.

2.Lower Defect Rate and Quality Costs

The equipment achieves a detection precision of up to 0.01mm, identifying subtle defects that are difficult for humans to detect, and enabling 360°full inspection without blind spots. This avoids missed inspections. By strictly implementing standardized quality processes, it controls product quality from the source, reducing costs associated with returns, rework, and compensation caused by defective products entering the market. Statistics show that precise detection effectively lowers the defect rate, saving substantial quality costs for enterprises.

3.Reduced Management Costs

Manual inspection lacks record-keeping and statistical capabilities, making it difficult to trace the root causes of problems and increasing management complexity. Detection machines, however, have traceable image and record functions, providing detailed logs of inspection processes and results. This facilitates quality analysis and management decision-making, reducing hidden costs from poor management.

(二) Efficiency Improvement

1.Dramatic Increase in Detection Speed

The equipment supports production line speeds of up to 400m/min, with an image reading speed of just 0.03 seconds. Combined with deep algorithm optimization, it achieves millisecond-level processing. Compared to the slow speed of manual inspection and its inability to detect small defects at high speeds, the detection machine adapts to high-speed production rhythms, ensuring accurate defect detection during rapid production and enhancing production flow continuity.

2.High Detection Accuracy and Stability

Using CNN deep learning algorithms and adaptive sensitivity, combined with a professional lighting system featuring special wavelengths, high brightness, and optimized structure, the machine resists interference from water droplets, vibrations, external sunlight, and fluorescent lights. This ensures stable operation in complex environments, with detection accuracy far exceeding manual inspection. It eliminates fluctuations in inspection results caused by human fatigue or experience differences, providing a reliable guarantee for product quality.

3.High Automation and Easy Operation

The machine is controlled quickly and conveniently via a touchscreen, automatically identifying and marking defect locations, with adjustable camera functions. It does not require long-term attendance by professional technicians—ordinary operators can get started after simple training, improving operational efficiency and reducing human error.

Ⅲ、Equipment Configuration and Performance Assurance

(一) Hardware Configuration

● Power supply: AC220V, 50HZ

● Dimensions: LWH = 400mm700mm1750mm

● Frame material: Aluminum profiles and other non-electrical components (aluminum profiles, aluminum, and steel plates)

● The standard version features practical configurations suitable for installation and use in various production environments.

(二) Software and Algorithms

Equipped with advanced image algorithms based on deep mathematical modeling and CNN deep learning, enabling precise defect recognition. The special lighting system has excellent illumination angles and color temperature, with stable quality verified through compatibility tests, providing a solid foundation for high-quality image acquisition.

(三) Services and Guarantees

Comprehensive training services cover system overview, principles, hardware, and software operations, targeting operators, diagnostic personnel, and maintenance staff to ensure proficiency in usage and maintenance. The equipment comes with a 1-year warranty, eliminating post-purchase concerns for enterprises.

Ⅳ、Practical Application Scenarios and Value

This detection machine is suitable for inspecting various products, including automotive tubing, cables, and medical tubing. In real-world applications, it delivers significant cost reduction and efficiency enhancement:

Example: Automotive Tubing ProductionHigh-speed detection ensures timely identification of surface defects during rapid production, preventing defective products from proceeding to subsequent processes and reducing rework and material waste. Precise inspection improves product quality, strengthens customer trust, and enhances the enterprise’s market competitiveness.

Media Contact
Company Name: Advance Technology Shanghai Co. ,ltd.
Email: Send Email
Country: China
Website: https://www.advancevi.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Advance Surface Defect Detection Machine: Cost Reduction and Efficiency Enhancement Solution

UHN Plus Surpasses 2.16 Billion Social Media Impressions in the First Five Months of 2026

“UHN Plus Logo”

UHN Plus Media Network, Inc. is an emerging digital media platform specializing in news, health, sports, and lifestyle content. With a strong presence on X, Instagram, Facebook, and Threads, the company combines journalistic excellence with innovative distribution strategies to effectively reach Hispanic and global audiences.

Coral Gables, Florida – June 1, 2026 – UHN Plus Media Network, Inc., one of the fastest-growing digital media startups in the United States, announced today that it has surpassed 2.16 billion impressions across social media platforms during the first five months of 2026 (January through May).

According to official platform analytics, the company achieved the following cumulative results:

• X (formerly Twitter): 358.4 million impressions

• Instagram: 581.3 million views

• Facebook: 765.2 million views

• Threads: 459 million views

These impressive figures confirm a total of more than 2.16 billion impressions generated in just five months, showcasing strong and consistent audience reach.

“This milestone of over 2.16 billion impressions in the first five months of 2026 reflects the hard work of our entire team and the growing trust of our audience in our content,” said Yan Estrada, Founder and CEO of UHN Plus Media Network, Inc. “We are proud to deliver relevant, high-quality information at such scale.”

Under the leadership of Yan Estrada, in strategic partnership with Javier Negre and Yulier Suárez, UHN Plus Media Network, Inc. continues to establish itself as one of the most influential and fastest-rising Hispanic media startups in the United States and Latin America. With this outstanding performance, UHN Plus Media Network, Inc. is exceptionally well-positioned to close the first half of 2026 on a high note and sustain strong momentum throughout the year.

Media Contact
Company Name: UHN Plus Media Network, Inc
Contact Person: Yan Estrada
Email: Send Email
Phone: 3053393616
Address:523 Anastasia Ave
City: Coral Gables
State: uhnplus.com
Country: United States
Website: uhnplus.com

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: UHN Plus Surpasses 2.16 Billion Social Media Impressions in the First Five Months of 2026

Exterior Alliance Showcases James Hardie Alliance Select Contractor Status as a Mark of Trusted Installation

Exterior Alliance is proud to showcase its James Hardie Alliance Select Contractor status as a reflection of the company’s commitment to trusted siding installation, strong workmanship, and long term protection for homeowners across Central Ohio.

As homeowners become more careful about who they trust with exterior renovations, manufacturer recognition can help separate experienced contractors from the rest. Exterior Alliance says its James Hardie Alliance Select Contractor status is one more way homeowners can feel confident that they are working with a company that values proper installation methods, product knowledge, and attention to detail.

James Hardie siding has become one of the most recognized names in the exterior remodeling space because of its durability, design versatility, and performance in changing climates. In Ohio, where homes are exposed to heat, humidity, rain, wind, and freezing temperatures throughout the year, choosing the right siding product and the right installer matters.

Exterior Alliance has continued to build its reputation by helping homeowners improve both protection and curb appeal through roofing and premium siding solutions. By highlighting its James Hardie Alliance Select Contractor status, the company aims to show homeowners that quality installation is not something to take lightly. Even the best material can fall short if it is installed incorrectly.

“At Exterior Alliance, we know homeowners want more than a product. They want to know the company installing it can be trusted,” said Dan Blanton of Exterior Alliance. “Our James Hardie Alliance Select Contractor status helps reinforce that commitment. We take pride in delivering siding installations that look great, perform well, and give homeowners confidence in their investment.”

For many homeowners, siding is one of the most important exterior upgrades they will make. It affects appearance, maintenance demands, energy efficiency, and the overall condition of the home. Exterior Alliance believes that manufacturer aligned training, installation standards, and field experience all play a role in helping customers make a smarter decision when choosing a contractor.

The company serves homeowners throughout Central Ohio and continues to focus on high quality exterior improvement services backed by communication, professionalism, and a customer first approach. As interest in durable siding options keeps growing, Exterior Alliance sees James Hardie siding as an important solution for homeowners who want a balance of beauty, performance, and long term value.

By showcasing its James Hardie Alliance Select Contractor status, Exterior Alliance hopes to give homeowners added peace of mind as they compare contractors and plan future siding projects. The company encourages homeowners to ask questions, understand the installation process, and choose a contractor with the experience and credibility to do the job right.

Homeowners interested in learning more about James Hardie siding installation or other exterior renovation services can contact Exterior Alliance directly for more information.

About Exterior Alliance

Exterior Alliance is a Dublin, Ohio based exterior renovation company serving homeowners across Central Ohio. The company specializes in roofing, siding, gutters, and related exterior services with a focus on reliable craftsmanship, honest communication, and long term customer value.

Media Contact
Company Name: Exterior Alliance
Contact Person: Dan Blanton
Email: Send Email
Phone: 614-954-7663
Address:6631 Commerce Parkway, Suite S
City: Dublin
State: https://exterioralliance.com/
Country: United States
Website: https://exterioralliance.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Exterior Alliance Showcases James Hardie Alliance Select Contractor Status as a Mark of Trusted Installation

LAVA Head Spa Brings Japanese Head Spa Ritual to Miami & NJ | Scalp Wellness

Lava Head Spa

LAVA Head Spa Brings Japan’s Fastest-Growing Wellness Ritual to Miami and New Jersey, Redefining Scalp Health and Luxury Relaxation. Bi-coastal head spa pioneers a Japanese-inspired scalp wellness experience as searches for “Japanese head spa” surge 233% year over year.

PINECREST, FL – Jun 1, 2026 – LAVA Head Spa, the bi-coastal Japanese-inspired head spa with locations in Pinecrest, Florida and Ridgewood, New Jersey, today announced the continued expansion of its signature scalp wellness experience as consumer demand for Japanese head spa treatments reaches a record high. With searches for “Japanese head spa” up 233% year over year and over 360 million related views across social media, LAVA is positioned at the center of one of the most viral wellness movements of the decade.

Founded by Monica Fernandez a licensed cosmetologist with over a decade of professional experience LAVA Head Spa offers a luxury head spa experience rooted in centuries-old Japanese ritual, where the scalp is treated as the center of full-body wellness. Each visit blends deep scalp massage, a multi-step scalp detox, hot stone therapy, custom aromatherapy, and a signature scent inspired by botanicals from volcanic regions around the world.

“In Japan, the scalp has been honored as the foundation of relaxation, beauty, and balance for centuries,” said Monica Fernandez, founder of LAVA Head Spa. “After more than ten years working hands-on with clients as a cosmetologist, I built LAVA because I wanted to give people something the American beauty industry has been missing a true sanctuary for the scalp, designed around the rituals I’ve spent my career perfecting.”

THE LAVA SYSTEM™: A Five-Step Scalp Wellness Experience

Every LAVA guest moves through The LAVA System™, the company’s proprietary consultation framework:

L — Listen Understand each guest’s lifestyle, stress, and goals

A — Analyze Examine scalp condition, hair texture, and routine

V — Vision Co-create a personalized scalp wellness plan

A — Address Deliver a tailored head spa ritual

S — Sustain Build a long-term routine for lasting results

WHY HEAD SPA, AND WHY NOW

The global head spa movement sometimes called the “facial for your Scalp” has exploded in popularity as consumers shift from surface-level beauty toward holistic wellness. Where traditional salons focus on the hair shaft, a head spa focuses on the scalp environment: relaxation, circulation, balance, and a healthy foundation for hair growth.

“Stress lives in the scalp,” said Fernandez. “What we’ve built is part wellness ritual, part self-care escape, and part education. People walk out of LAVA feeling lighter, calmer, and more in tune with their bodies — and they finally understand their own hair for the first time.”

LAVA’s scalp facials and Japanese head spa treatments incorporate add-on experiences including red light therapy, high-frequency therapy, the LAVA Lift microcurrent treatment, hot stone candle massage, custom aromatherapy, scalp oiling, mini glass facials, a pregnancy-safe ritual, and rotating seasonal experiences such as the Pumpkin Plump and Fall Detox.

TWO LOCATIONS, ONE PHILOSOPHY

LAVA Head Spa currently operates two flagship locations:

• LAVA Head Spa Pinecrest — Pinecrest, FL

• LAVA Head Spa Ridgewood — Ridgewood, NJ

A third location in Lakewood Ranch, Florida is planned as part of LAVA’s multi-state expansion. Each location is designed as a multi-sensory escape — soft lighting, custom aroma, warm towels, hand-poured candles, and trained scalp specialists who guide every guest through the LAVA ritual.

ABOUT LAVA HEAD SPA

LAVA Head Spa is a Japanese-inspired luxury head spa offering scalp facials, scalp detox, scalp massage, and full-body relaxation services across Florida and New Jersey. The name “LAVA” is drawn from the Spanish word lavar — to wash, to cleanse — and the volcanic energy of transformation. Founded by Monica Fernandez, a licensed cosmetologist with over a decade of professional experience, LAVA delivers a signature head spa experience built on Japanese ritual, personalized service, and an unwavering commitment to client care.

Booking and gift cards are available at www.lavaheadspa.com.

Media Contact
Company Name: Lava Head Spa
Contact Person: Steven Fernandez
Email: Send Email
Phone: (201)613-2308
Address:235 E Ridgewood Ave
City: Ridgewood
State: New Jersey
Country: United States
Website: http://www.lavaheadspa.com/

2026 BRICS New Connectivity Innovation Forum Held in Xiamen, Outlining a New Blueprint for AI-Empowered Global Digital Cooperation

On May 26, the 2026 BRICS New Connectivity Innovation Forum concluded successfully at the Xiamen International Conference Centre. Under the core theme of “AI-Driven New Connectivity for a New Future of BRICS Cooperation,” the forum was co-hosted by four major international alliances: the World WLAN Application Alliance (WAA), the International SparkLink Wireless Short-range Communication Alliance (iSLA), the Network Innovation and Development Alliance (NIDA), and the Global Intelligent Internet of Things Consortium (GIIC). It was co-organized by the BRICS New Connectivity Committee and Center for International Economic and Technological Cooperation Ministry of Industry and Information Technology. Government representatives, communication operators, industry leaders, and technical experts from BRICS nations and partner countries, including China, Egypt, Indonesia, Kenya, Tajikistan, Nigeria, and Ethiopia, gathered to discuss cutting-edge trends in the digital industry, share practical experience in advanced technologies, and explore new horizons for digital cooperation among BRICS countries. The forum further facilitated multi-dimensional collaboration across technology, standards, industry, and markets, building a high-end, professional, and international platform for industrial exchange and resource alignment.

ZHU Gang, Deputy Director-general, Center for International Economic and Technological Cooperation, Ministry of Industry and Information Technology, China, stated in his address that new connectivity technologies are the core foundation of digital infrastructure, and that BRICS countries hold significant potential for cooperation in areas such as digital infrastructure connectivity. He noted that the Centre will focus on three areas: deepening policy coordination, strengthening talent development, and advancing project cooperation, while continuing to work closely with relevant international alliances to support the digital economic upgrading of all participating countries.

MA Yun, Director’s Assistant of the BRICS PartNIR Innovation Center, China, stated that new connectivity technologies are the core foundation of digital infrastructure. He emphasized that the BRICS Innovation Base will work closely with relevant organizations and enterprises to promote the application and project cooperation of emerging technologies across BRICS countries. Through initiatives such as the “Golden Eagle” scholarship programme, the Base aims to bring together young talents with global vision and innovation capacity, contributing global wisdom to digital development.

MA Yun, Director’s Assistant of the BRICS PartNIR Innovation Center, China

The forum officially released the Global WLAN Industry Development Research Report. The report focuses on the global WLAN technology, industry, and intellectual property development landscape, providing in-depth analysis of technological evolution, market competition dynamics, and future trends.

The forum closely followed the theme of integrated development of AI and new connectivity, focused on industry pain points and cutting-edge directions, and built a multi-level, diversified system for exchange and discussion. Multiple Chinese and international speakers shared their latest achievements in the practice and standard development of AI and new connectivity integration.

XIA Yi, General Manager of Home Smart Connectivity Department, China Mobile (Hangzhou) Information Technology Co., Ltd., China shared innovative practices in AI-driven home intelligence, proposing to fully upgrade the home digital experience through FTTR all-optical networking and AI capabilities, and expressing the intention to deepen cooperation with BRICS countries in the future. WANG Huanxi, Assistant to the General Manager, China Quality Certification Centre Co., Ltd., China (CQC) introduced the progress in building an AI certification matrix, as well as the work related to promoting AI WLAN evaluation grading standards and certification in cooperation with WAA. HU Caiyong, Secretary-General, Global Intelligent Internet of Things Consortium (GIIC), shared the achievements in building a core IoT digital foundation based on the open-source HarmonyOS, and put forward three major cooperation initiatives: mutual standard recognition, joint innovation, and joint talent development. LI Kun, Director of Industrial Development, Network Innovation and Development Alliance (NIDA), elaborated on the trend of next-generation networks evolving toward the characteristics of “four connections and four innovations” in the intelligent era, and noted that several standards have already been adopted by BRICS countries. ZHEN Bin, Director of Standard and Certification, International SparkLink Wireless Short-range Communication Alliance (iSLA), introduced the features of SparkLink technology, including low latency, high reliability, and high concurrency, as well as its application prospects in scenarios such as smart cockpits.

Several international speakers also shared their countries’ digital development visions and practical initiatives. Ahmed Salaheldin Mohamed Nour Gaber(Director of Business Development Operations for Global Information Infrastructure, Ministry of Communications and Information Technology, Egypt), Oki Suryowahono (Head of Strategic Policies Center, Ministry of Communication and Digital Affairs, Indonesia), Beryll Achieng Semmo (Principal ICT Officer, Ministry of ICT and Digital Economy, Kenya), Nazirov Jaloliddin Kamolovich (Deputy Head of Department of International Relation and Investment Attraction, Communication Service, Tajikistan), and Lamin Fatty (Principal Telecom Officer, Ministry of Communications and Digital Economy, The Gambia) delivered addresses. Their presentations focused respectively on the following themes: “AI-Driven New International Connectivity Co-creating a New Future for BRICS Cooperation,” “AI-Driven NewConnectivity Indonesia’s Opportunity for Inclusive and Sovereign Digital Cooperation,” “Bilateral Digital Connectivity,” “AI Strategic Cooperation,” and “AI-Driven New Connectivity, Co-creating a New Future for BRICS Cooperation.” In their remarks, they elaborated on their respective countries’ cooperation concepts and initiatives driven by AI and new connectivity technologies, while expressing their willingness to deepen standard coordination, project collaboration, and talent exchange within the BRICS framework.

A special panel session, themed “Empower Innovation through Science & Technology, Build Connected Ecosystems: AI Technological Innovation and Industrial Collaborative Development,” was held. Experts from the China Quality Certification Centre, China Mobile (Hangzhou) Information Technology Co., Ltd., Fiberhome Telecommunication Technologies Co.,LTD, ZTE Corporation, HiSilicon Technologies Co., Ltd., and a representative from Nigeria’s Federal Ministryof Industry, Trade & Investment participated in in-depth discussions. The participants agreed that the deep integration of AI and WLAN is driving the industry from “ubiquitous connectivity” to “intelligent perception,” a process in which BRICS countries have significant potential for synergy. In the future, a multi-stakeholder effort—comprising government guidance, alliance coordination, institutional support, and enterprise leadership—will be essential to jointly promote the high-quality development of the wireless industry among BRICS countries and contribute to global digital inclusion.

Since its establishment in 2024 by the Center for International Economic and Technological Cooperation Ministry of Industry and Information Technology and WAA, the BRICS New Connectivity Committee has successfully organized multiple international exchange activities, building a comprehensive cooperation network covering governments, industry organizations, operators, equipment manufacturers, standardization bodies, and research institutes. It has continuously advanced the full-chain process of “joint standard development-national adoption-commercial implementation.”

As the secretariat unit of the BRICS New Connectivity Committee, WAA has consistently focused on strategic coordination and practical cooperation in the field of new connectivity technologies among BRICS countries. This forum further amplified the influence of the AI and new connectivity industrial and innovation chains within the BRICS region, laying a solid foundation for coordinated digital economic development among BRICS countries and the construction of a new global digital cooperation landscape.

Media Contact
Company Name: WAA
Contact Person: Media Relations
Email: Send Email
Country: China
Website: https://www.waa-alliance.com/

An Incandescent, Darkly Witty Novel About Motherhood, Marriage and Melancholy by Monika Killeen’s

Edge of Me introduces Myrtle: mother, wife, writer, therapist — an ordinary woman whose day fractures into startling clarity. With razor wit and tender authority, Monika Killeen traces a single day that expands into a life. Its small domestic obligations, the private economies of love, the patients she listens to and the inner weather she must endure.

Killeen blends the concrete with the uncanny, a watching Baba Yaga figure threads myth through the rooms of Myrtle’s life, while remaining rooted in forensic emotional realism. The result is a book that is sharp and humane, wry and sorrowful, where scenes of family friction and infant rage sit beside moments of fierce tenderness and reluctant repair.

Edge of Me opens doors we habitually lock. Marriage’s compromises, parenthood’s quiet devastations, the slow accretion of trauma and the work of becoming someone kinder to herself. Myrtle is not heroic. She is stubbornly human — frail, contradictory, funny and fiercely alive. That honesty is the novel’s strength.

Readers who prize literary fiction that interrogates interior life will find Killeen’s voice both startling and consoling. Edge of Me makes the ordinary feel sharp enough to cut and kind enough to heal.

Edge of Me by Monika Killeen is available now. For readers who know that repair comes in fragments, this is a book that remains in the bones.

Book Name: Edge of Me

Author Name: Monika Killeen

ISBN Number: 9781971610160

Waterstones link: Click Here

Barnes and Nobel Link: Click Here

Ebook Version: Click Here

Paperback Version: Click Here

Media Contact
Company Name: Books Publishing Company
Email: Send Email
Phone: +1-281-807-3232
Address:2425 West Loop South
City: Houston
State: Texas
Country: United States
Website: https://bookspublishingcompany.com

AlignMark Helps Organizations Improve Hiring and Leadership Development with Pre-Employment Testing & 360-Degree Feedback Solutions

A Proven Leader in Workforce Assessment

Maitland, FL – AlignMark continues to support organizations seeking more effective ways to evaluate, hire, and develop talent. With more than 40 years of workforce assessment experience, AlignMark delivers science-based solutions that help businesses identify high-quality candidates, streamline screening processes, and strengthen leadership performance. The company has evaluated millions of applicants worldwide, helping organizations make more confident hiring and development decisions through data-driven insights.

Advanced Pre-Employment Screening Tools

Modern hiring challenges require reliable evaluation systems that go beyond traditional resume reviews. AlignMark provides comprehensive pre-employment testing and hiring solutions designed to measure candidate capabilities, job fit, and long-term potential. These tools help organizations reduce screening time while improving the quality of hires.

Solutions such as AccuRecruiter provide structured assessment tools that help employers identify top talent early in the hiring process. By integrating validated testing methodologies, organizations gain deeper visibility into candidate strengths, ensuring more accurate hiring decisions and stronger workforce outcomes.

Leadership Development Through 360-Degree Feedback

Beyond hiring, AlignMark also supports leadership growth through robust feedback and development programs. The company’s AccuVision platform delivers comprehensive 360-degree feedback that gathers insights from supervisors, peers, and team members. This structured evaluation approach helps leaders better understand performance strengths and development opportunities, encouraging continuous professional growth and stronger organizational leadership.

Driving Better Talent Decisions

As organizations continue to seek ways to build stronger teams and future leaders, AlignMark remains focused on delivering scalable assessment and feedback solutions. The company’s tools support smarter hiring, improved employee development, and stronger workforce performance across industries.

Organizations interested in learning more about these solutions can schedule a demo with AlignMark to explore how science-based assessments and leadership feedback tools can enhance hiring accuracy and talent development strategies.

Media Contact
Company Name: AlignMark
Contact Person: Cabot Jaffee
Email: Send Email
Phone: 1.800.682.4587
Address:2400 Maitland Center Parkway, Ste 114
City: Maitland
State: FL 32751
Country: United States
Website: https://www.alignmark.com/

Global Management Guru Dave Ulrich Delivers ACTION EDUCATION “Entrepreneurs EMBA” Masterclass in Shanghai

As the global economy searches for new growth drivers amid turbulence and restructuring, the spotlight of the management world has once again turned to the East. On May 31, 2026, Dave Ulrich — widely recognized as the “Father of Modern Human Resources” and the founding architect of organizational capability theory — appeared in Shanghai as an international mentor for ACTION EDUCATION’s “Entrepreneurs EMBA” program. He delivered a thought-provoking masterclass titled Winning Through Organization to hundreds of entrepreneur participants and principals enrolled in the program. More than just a course, the event signaled China’s proactive effort at the microeconomic level to benchmark itself against world-class standards.

China’s Moment in a Global Context: Chinese Enterprises Elevate Organizational Capability

At a time when deglobalization trends intersect with technological revolution, the focus of international competition has shifted from the surface level of trade and technology to the deeper dimensions of organizational systems and management philosophy.

As the thought leader who defined the modern three-pillar HR model and influenced half of the Fortune 500 companies worldwide, Ulrich stated during the session:

“Strategies can be copied, and technologies can be overtaken. But an organizational system with high adaptability and strong learning capability is the ultimate competitive barrier that cannot easily be replicated.”

During the class, Ulrich systematically presented a comprehensive “organizational capability framework” developed through seven rounds of global longitudinal research spanning more than 30 years. Rather than a simple transplantation of Western theory, the framework represents a universal set of principles distilled from one of the world’s largest research samples on how enterprises can continuously create value amid uncertainty.

For Chinese entrepreneurs, engaging with and internalizing these principles signifies that, on the journey toward building “world-class enterprises,” Chinese companies are becoming pioneering explorers of future organizational models.

Dave Ulrich

Using “World-Leading” Standards to Address Corporate Weaknesses: The Essential Path Toward Management Modernization

For many years, Western management circles tended to attribute the success of Chinese enterprises primarily to “market dividends” and “demographic dividends.” However, the “Entrepreneurs EMBA” masterclass painted an entirely different picture: Chinese entrepreneurs are collectively transitioning toward a new stage centered on “building organizations.”

During the course, Ulrich not only explained how to build a talent supply chain and define corporate culture from the outside in, but also emphasized the role of “human competitiveness” as the micro-foundation of national industrial competitiveness.

In the subsequent practical transformation session, ACTION EDUCATION Chairman and CEO Li Jian pointed out that, in the new phase of globalization, Chinese enterprises must complete a cognitive revolution driven by capability-building. By introducing a world-class mentor like Ulrich, Chinese companies can reassess their organizational health through international standards and address the micro-level weaknesses constraining high-quality development.

This collision between “global top-tier think tanks” and “Chinese real-world business practice” is providing valuable “China samples” for the evolution of global management theory.

Li Jian

Connecting the World and Empowering the Future: A Collective March Toward Building World-Class Enterprises

Notably, the masterclass adopted an innovative model that combined “guidance from world-renowned experts” with “localized practical transformation.” After Ulrich established the global strategic perspective, Li Jian immediately followed with a localized implementation course tailored to Chinese business realities.

This two-way exchange transcends traditional business education. It demonstrates that, under the broader vision of building a community with a shared future for mankind, Chinese management education is taking on a new role in promoting mutual learning among civilizations — bringing in the world’s most advanced wisdom while transforming it into practical methodologies that serve the growth of the real economy.

As Ulrich concluded at the end of the session:

“Future competition will be competition between organizations, and ultimately, that competition will be reflected in competition between nations.”

As hundreds of influential entrepreneurs from various industries gathered in Shanghai to learn how to “win through organization,” the event represented not only a corporate capability-building initiative, but also a collective movement aimed at strengthening management soft power and advancing the goal of building world-class enterprises.

Media Contact
Company Name: Shanghai Action Education Technology Co., Ltd.
Contact Person: Carol Chu
Email: Send Email
Phone: +86 13661437173
Country: China
Website: www.xdjy100.com